News

Endeavor BioMedicines, a clinical-stage biotechnology company targeting the core drivers of terminal diseases including oncology and fibrosis,  announced the completion of a $101 million Series B financing, led by Ally Bridge Group and Avidity Partners. New investors participating in...

The life science group Sartorius announced today that, through its subgroup Sartorius Stedim Biotech, it closed the acquisition of the Novasep chromatography division as of February 7, 2022, following approval by the U.S. Federal Trade Commission. The transaction had...

An investment consortium led by Signet Healthcare Partners, Bionpharma, Inc and GMS Capital Partners LLC today announced it has formed Pharma Nobis, LLC to acquire Fagron’s US contract manufacturing business. This business unit, operating from a manufacturing facility in...

Samsung Biologics, the world’s leading contract development and manufacturing organization (CDMO), announced that it has been selected as a winner of the 2022 CMO Leadership Awards presented by Outsourced Pharma and Life Science Leader. Samsung Biologics received a total...

Fumio Kishida, the Japanese Prime Minister, has recently gone on record to say that he is looking to speed up the country’s COVID-19 booster shots to 1 million a day by the end of February. This figure will be...

It’s been two years since the COVID-19 virus emerged giving way to several new variants that have consistently knocked on the doors. However, to lessen the infection and other related consequences to a significant extent, the vaccination drive has...

According to a recently conducted study in the US, a patch of severe COVID-19 on some children could lead to lasting neurological complications, which is a part of a very rare condition known as multisystem inflammatory syndrome-Children ( MIS-C). These...